Using Heart Electrical Signals to Study How Well Treatments Prevent Dangerous Heart Rhythms in Active People
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ghulam André Ng, MBChB, MRCP, Ph.D, FRCP
University of Leicester, Leicestershire, United Kingdom
Study Director - Ghulam André Ng, MBChB, MRCP, Ph.D, FRCP, FHEA
University of Leicester, Leicestershire, United Kingdom
Principal Investigator - Harshil Dhutia, MBBS, BSC, MRCP, CCDS, MD(RES)
Glenfield Hospital, Leicester
Principal Investigator - Xin Li, PhD, MSc, BSc, FHEA
University of Leicester, Leicestershire, United Kingdom
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Glenfield Hospital
Leicester, Leicestershire, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jun 2025
- Primary completion
- 31 Jul 2026
- Completion
- 31 Jul 2026
- Last update posted
- 11 Jun 2025
- Registered enrollment
- 40
- Registry id
- NCT07014579
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.